Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6

2017 ◽  
Vol 46 (8) ◽  
pp. 711-721 ◽  
Author(s):  
T. He ◽  
M. A. Lopez-Olivo ◽  
C. Hur ◽  
J. Chhatwal
Keyword(s):  
Systematic Review ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Direct Acting Antivirals ◽  
Direct Acting

Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review

2018 ◽  
Vol 12 (12) ◽  
pp. 1251-1263 ◽  
Author(s):  
Jaume Puig-Junoy ◽  
Natàlia Pascual-Argente ◽  
Lluc Puig-Codina ◽  
Laura Planellas ◽  
Míriam Solozabal
Keyword(s):  
Systematic Review ◽  
Hepatitis C ◽  
Second Generation ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Direct Acting Antivirals ◽  
Utility Analysis ◽  
Direct Acting

scholarly journals Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis

PLoS ONE ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. e0229143 ◽  
Author(s):  
Rodolfo Castro ◽  
Hugo Perazzo ◽  
Letícia Artilles Mello Mendonça de Araujo ◽  
Isabella Gonçalves Gutierres ◽  
Beatriz Grinsztejn ◽  
...  
Keyword(s):  
Systematic Review ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Meta Analysis ◽  
Direct Acting Antivirals ◽  
Direct Acting

Efficacy and safety of direct‐acting antivirals for hepatitis C in the elderly: A systematic review and meta‐analysis

2019 ◽  
Vol 39 (9) ◽  
pp. 1652-1660 ◽  
Author(s):  
Marcus M. Mücke ◽  
Eva Herrmann ◽  
Victoria T. Mücke ◽  
Christiana Graf ◽  
Stefan Zeuzem ◽  
...  
Keyword(s):  
Systematic Review ◽  
Hepatitis C ◽  
Meta Analysis ◽  
The Elderly ◽  
Efficacy And Safety ◽  
Direct Acting Antivirals ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document